Patent Assignment
Reel/Frame 035551/0219
Merger
Recorded: 2015-04-29
Pages: 4
Assignor
SIGMA TAU RARE DISEASES S.A.
Executed: 2013-10-03
Assignee
SIGMA-TAU PHARMA LIMITED
21 HOLBORN VIADUCT, LONDON, EC1A2DY, UNITED KINGDOM
Covered Properties
(9)
Methods of Preparing Low-Toxicity Drug-Lipid Complexes
Patent:
6,406,713 →
Application:
08/430,661 →
Low Toxicity Drug-Lipid Systems
Patent:
5,616,334 →
Application:
08/430,699 →
Method of Treating CD4+ T Cell Lymphopenia in Immuno-Compromised Patients
Patent:
5,728,560 →
Application:
08/663,685 →
Composition and Methods for Treatment of Hiv Infection
Patent:
6,689,762 →
Application:
09/370,390 →
Recombinant Host for Producing L-Asparaginase Ii
Connector Enabling Multiple Sampling of Sealed Environment
Adenosine Deaminase Anticancer Therapy
Stable Recombinant Adenosine Deaminase
Recombinant Host for Producing L-Asparaginase Ii
Application:
12/773,320 →
Publication:
US 2010/0273236
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 23, 1996
From: CLARK, MIKE A.
To: ENZON, INC.
Reel/Frame 008145/0135 →
Assignment of Assignor's Interest
Sep 23, 1996
From: SHORR, ROBERT G.L.
To: ENZON, INC.
Reel/Frame 008145/0133 →
Assignment of Assignor's Interest
Nov 25, 1996
From: GODDARD, DAVID H.
To: ENZON, INC.
Reel/Frame 008244/0222 →
Merger
Jun 14, 2002
From: LIPOSOME COMPANY, INC., THE
To: ELAN PHARMACEUTICALS, INC.
Reel/Frame 012958/0601 →
Assignment of Assignor's Interest
Feb 12, 2003
From: ELAN PHARMACEUTICALS, INC.
To: ENZON, INC.
Reel/Frame 013746/0545 →
Change of Name
Feb 13, 2003
From: RHONE-POULENC RORER PHARMACEUTICALS INC.
To: AVENTIS PHARMACEUTICALS PRODUCTS INC.
Reel/Frame 013430/0123 →
Change of Name
Feb 13, 2003
From: AVENTIS PHARMACEUTICALS PRODUCTS INC.
To: AVENTIS PHARMACEUTICALS INC.
Reel/Frame 013428/0871 →
Assignment of Assignor's Interest
Mar 7, 2003
From: AVENTIS PHARMACEUTICALS, INC.
To: ENZON PHARMACEUTICALS, INC.
Reel/Frame 013471/0644 →
Assignment of Assignor's Interest
Jun 5, 2003
From: AVRAMIS, VASSILIOS; COHEN, LEWIS
To: ENZON PHARMACEUTICALS, INC.
Reel/Frame 014145/0104 →
Assignment of Assignor's Interest
Jun 26, 2007
From: FILPULA, DAVID RAY; WANG, MAOLIANG
To: ENZON PHARMACEUTICALS, INC.
Reel/Frame 019479/0476 →
Assignment of Assignor's Interest
Jul 19, 2007
From: EVANS, ROY L.
To: ENZON PHARMACEUTICALS, INC.
Reel/Frame 019577/0781 →
Assignment of Assignor's Interest
Jun 13, 2008
From: FILPULA, DAVID R; SAPRA, PUJA
To: ENZON PHARMACEUTICALS, INC.
Reel/Frame 021093/0804 →
Assignment of Assignor's Interest
Jun 16, 2008
From: FILPULA, DAVID R.; YOUNGSTER, STEPHEN K.
To: ENZON PHARMACEUTICALS, INC.
Reel/Frame 021099/0336 →
Assignment of Assignor's Interest
Feb 16, 2010
From: ENZON PHARMACEUTICALS, INC.
To: DEFIANTE FARMACEUTICA, S.A.
Reel/Frame 023937/0530 →
Change of Name
Feb 16, 2010
From: ENZON, INC.
To: ENZON PHARMACEUTICALS, INC.
Reel/Frame 023937/0543 →
Corrective Assignment to Correct the Applicant's Address Must Be Corrected in the Electronic Patent Assignment System Previously Recorded on Reel 023937 Frame 0533. Assignor(S) Hereby Confirms the Correct Address Is Rua Dos Ferreiros 260, Funchal-Madeira, Portugal, 9000-082.
Apr 26, 2010
From: ENZON PHARMACEUTICALS, INC.
To: DEFIANTE FARMACEUTICA, S.A.
Reel/Frame 024286/0076 →
Assignment of Assignor's Interest
Jun 28, 2010
From: ENZON PHARMACEUTICALS, INC.
To: DEFIANTE FARMACEUTICA, S.A.
Reel/Frame 024599/0071 →
Assignment of Assignor's Interest
Feb 7, 2012
From: DEFIANTE FARMACEUTICA, S.A.
To: SIGMA-TAU RARE DISEASES, S.A.
Reel/Frame 027662/0812 →
Assignment of Assignor's Interest
Jul 1, 2015
From: SIGMA-TAU PHARMA LIMITED
To: SIGMA-TAU RARE DISEASE LTD
Reel/Frame 035948/0139 →
Change of Name
Dec 12, 2016
From: SIGMA-TAU RARE DISEASE LIMITED
To: LEADIANT BIOSCIENCES LIMITED
Reel/Frame 040716/0853 →
Change of Name
Sep 10, 2019
From: SERVIER UK IP LIMITED
To: SERVIER IP UK LIMITED
Reel/Frame 050327/0069 →
Change of Name
Sep 10, 2019
From: SIGMA-TAU PHARMA LIMITED
To: SERVIER UK IP LIMITED
Reel/Frame 050326/0766 →
Change of Address
Sep 10, 2019
From: SIGMA-TAU PHARMA LIMITED
To: SIGMA-TAU PHARMA LIMITED
Reel/Frame 050326/0395 →
Assignment of Assignor's Interest
Dec 14, 2020
From: LEADIANT BIOSCIENCES LIMITED
To: UNIKERIS LIMITED
Reel/Frame 054641/0399 →
Change of Address
Mar 17, 2021
From: UNIKERIS LIMITED
To: UNIKERIS LIMITED
Reel/Frame 055616/0640 →